BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30080993)

  • 1. Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine.
    Kim K; Yao J; Jin Z; Zheng F; Zhan CG
    Chem Biol Interact; 2018 Sep; 293():107-114. PubMed ID: 30080993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine.
    Salmon AY; Goren Z; Avissar Y; Soreq H
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):596-600. PubMed ID: 10474772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine.
    Qiao Y; Han K; Zhan CG
    Org Biomol Chem; 2014 Apr; 12(14):2214-27. PubMed ID: 24595354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene.
    Zheng X; Chen X; Zhang T; Zhan M; Zhan CG; Zheng F
    Org Biomol Chem; 2020 Mar; 18(10):1968-1977. PubMed ID: 32101217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.
    Kamendulis LM; Brzezinski MR; Pindel EV; Bosron WF; Dean RA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):713-7. PubMed ID: 8930175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.
    Hou S; Zhan M; Zheng X; Zhan CG; Zheng F
    Biochem J; 2014 Jun; 460(3):447-57. PubMed ID: 24870023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.
    Zhan M; Hou S; Zhan CG; Zheng F
    Biochem J; 2014 Jan; 457(1):197-206. PubMed ID: 24125115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine.
    Xue L; Hou S; Tong M; Fang L; Chen X; Jin Z; Tai HH; Zheng F; Zhan CG
    Biochem J; 2013 Aug; 453(3):447-54. PubMed ID: 23849058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
    Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
    Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.
    Xie W; Altamirano CV; Bartels CF; Speirs RJ; Cashman JR; Lockridge O
    Mol Pharmacol; 1999 Jan; 55(1):83-91. PubMed ID: 9882701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin.
    Gottås A; Boix F; Øiestad EL; Vindenes V; Mørland J
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1357-65. PubMed ID: 24576415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
    Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
    Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases.
    Gao D; Zhan CG
    J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-engineering butyrylcholinesterase as a cocaine hydrolase.
    Sun H; Pang YP; Lockridge O; Brimijoin S
    Mol Pharmacol; 2002 Aug; 62(2):220-4. PubMed ID: 12130672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
    Yang W; Xue L; Fang L; Chen X; Zhan CG
    Chem Biol Interact; 2010 Sep; 187(1-3):148-52. PubMed ID: 20060817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin.
    Qiao Y; Han K; Zhan CG
    Biochemistry; 2013 Sep; 52(37):6467-79. PubMed ID: 23992153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
    Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice.
    Bogen IL; Boix F; Nerem E; Mørland J; Andersen JM
    J Pharmacol Exp Ther; 2014 Jun; 349(3):568-76. PubMed ID: 24700886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase.
    Chen X; Huang X; Geng L; Xue L; Hou S; Zheng X; Brimijoin S; Zheng F; Zhan CG
    Biochem J; 2015 Mar; 466(2):243-51. PubMed ID: 25486543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-Life.
    Cai Y; Zhou S; Jin Z; Wei H; Shang L; Deng J; Zhan CG; Zheng F
    AAPS J; 2019 Nov; 22(1):5. PubMed ID: 31754920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.